Role of phosphatidylinositide 3-kinase in brain-derived neurotrophic factor-induced DARPP-32 expression in medium size spiny neurons in vitro

Journal of Neurochemistry

Volumn 79, Issue 5, 2001, Pages 1027-1032

  Stroppolo, Antonella ^a   Guinea, Barbara ^a   Tian, Chai ^a   Sommer, John ^a   Ehrlich, Michelle E ^b,c  

^a Nathan Kline Institute   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Akt; Brain derived neurotrophic factor; DARPP 32; Erk; Striatum

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; DOPAMINE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN DARPP 32;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORPUS STRIATUM; GENETIC TRANSCRIPTION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TISSUE CULTURE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SIZE; CHROMONES; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; ENZYME INHIBITORS; FEMALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; NERVE TISSUE PROTEINS; NEURONS; PHOSPHOPROTEINS; PHOSPHORYLATION; PREGNANCY; SIGNAL TRANSDUCTION;

ANIMALIA; SPINY;

EID: 0035212784     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00651.x     Document Type: Article

References (40)

1. TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death
2. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
3. BDNF protects against spatial memory deficits following neonatal hypoxia-ischemia
4. Anterograde transport of brain-derived neurotrophic factor and its role in the brain
5. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral transfer
6. Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin
7. DARPP-32 development in the caudate nucleus is independent of afferent input from the substantia nigra
8. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
9. Brain-derived neurotrophic factor in Huntington's disease
10. CREB couples neurotrophin signals to survival messages
11. Activation of p44/p42 MAP kinase in striatal neurons via kainate receptors and PI3 kinase
12. Requirement for BDNF in activity-dependent survival of cortical neurons
13. Beyond the dopamine receptor: The DARPP-32/protein phosphatase-I cascade
14. 3 receptor expression and triggers behavioural sensitization
15. Ras controls growth, survival and differentiation in the Drosophila eye by different thresholds of MAP kinase activity
16. BDNF protect the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway
17. Neurotrophic factors NGF and FGF-2 alter levels of Huntington (IT15) in striatal neuronal cell cultures
18. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor
19. Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons required neurotrophins in vivo and in vitro
20. Brain-derived neurotrophic factor regulates maturation of the DARPP-32 phenotype in striatal medium spiny neurons: Studies in vivo and in vitro
21. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development
22. Alternate FGF2-ERK1/2 signaling pathways in retinal photoreceptor and glial cells in vitro
23. Evidence for neuroprotective effects of endogenous brain-derived neurotrophic factor after global forebrain ischemia in rats
24. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
25. Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: Regional distribution and regulation by chronic morphine
26. Quantitative immunocytochemisty of DARPP-32-expressing neurons in the rat caudatoputamen
27. Trk receptors: Mediators of neurotrophin action
28. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease
29. Role of phosphoinositide 3-OH and kinase in cell transformation and control of the actin cytoskeleton by Ras
30. The inhibition of phosphatidylinositol-3-kinase induces neurite retraction and activates GSK3
31. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
32. The Ras-ERK pathway is required for the induction of neuronal nitric oxide synthase in differentiating PC12 cell
33. Intracellular signaling pathways activated by neurotrophic factors
34. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior
35. Phosphoinositide 3-kinase induces the transcriptional activity of MEF2 proteins during muscle differentiation
36. Phosphatidylinositol 3-kinase is required for the trophic, but not the survival-promoting, actions of NGF on sympathetic neurons
37. Depolarization and neurotrophins converge on the phosphatidylinositol 3-kinase-Akt pathway to synergistically regulate neuronal survival
38. Role of phosphoinositide 3-kinase in activation of Ras and mitogen-activated protein kinase by epidermal growth factor
39. Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1
40. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease